HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

HKI 46F08

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - HKI 46F08: 1

Experts

1.	Deubzer, Hedwig E: 1 article (10/2008)
2.	Hildmann, Christian: 1 article (10/2008)
3.	Milde, Till: 1 article (10/2008)
4.	Oehme, Ina: 1 article (10/2008)
5.	Schwienhorst, Andreas: 1 article (10/2008)
6.	Wegener, Dennis: 1 article (10/2008)
7.	Witt, Olaf: 1 article (10/2008)

Related Diseases

1.	Neuroblastoma 10/01/2008 - "HKI 46F08 efficiently arrests tumor cell proliferation, represses clonogenic growth and induces differentiation and apoptosis in both MYCN-amplified and nonamplified neuroblastoma cells. "
2.	Neoplasms (Cancer) 10/01/2008 - "HKI 46F08 efficiently arrests tumor cell proliferation, represses clonogenic growth and induces differentiation and apoptosis in both MYCN-amplified and nonamplified neuroblastoma cells. " 10/01/2008 - "HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells."

Related Drugs and Biologics

1.	Histone Deacetylase Inhibitors